OR WAIT null SECS
May 11, 2023
EC has granted marketing authorization to Chiesi Global Rare Diseases and Protalix BioTherapeutics for PRX-102 (pegunigalsidase alfa).
Critical raw materials supplier, Biosynth, has acquired UK-based Cambridge Research Biochemicals (CRB).
Vetter is further expanding its production capacity and services at its Rankweil, Austria site.
May 10, 2023
The guidance is to provide information on compliance with applicable regulatory requirements and recommendations.
EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.
GSK’s Alexvy vaccine is the first to receive FDA approval for respiratory syncytial virus.
Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.
May 09, 2023
Boehringer Ingelheim will use Ginkgo’s metagenomic sequence database to identify potential lead molecules for diseases with high unmet patient needs.
According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.
The new portfolio from the acquisition will include contract research organization solutions, contract development and manufacturing organization solutions, and KSM/API solutions.